In one paragraphArticle in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
12 authors.
Diana J Arenas MachacaUnidad Funcional de Genética y Biología Molecular, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 15038, Peru.ORCID 0000-0001-6765-9430 Álvaro Martín de BernardoInstitute of Biomedical Research, Hospital Universitario 12 de Octubre (IMAS12), 28041 Madrid, Spain.ORCID 0009-0001-1626-3978 Daniel Alejandro Desposorio-VicenteGrupo de Investigación de Bioquímica y Biología Sintética-UNFV (GIBBS-UNFV), Laboratorio de Bioquímica y Biología Molecular, Facultad de Ciencias Naturales y Matemática, Universidad Nacional Federico Villarreal (UNFV), Lima 15007, Peru.ORCID 0000-0002-2402-2971 Sandro Casavilca-ZambranoUnidad Funcional de Gestión del Banco Nacional de Tumores, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 15038, Peru.ORCID 0000-0001-8406-739X Karen Yoshira Cruz-HualpaDepartamento de Mamas y Tejidos Blandos, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 15038, Peru.
Bijaya Milagros García-GómezGraduate Program in Bioinformatics and Omics Sciences, Postgraduate Unit, Faculty of Biological Sciences, National University of San Marcos (UNMSM), Lima 15081, Peru.ORCID 0009-0001-4214-3128 Tatiana VidaurreDepartamento de Oncología Médica, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 15038, Peru.
Yasser Sullcahuaman-AllendeUnidad Funcional de Genética y Biología Molecular, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 15038, Peru.
Juan Jose Contreras-MancillaUnidad Funcional de Gestión del Banco Nacional de Tumores, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 15038, Peru.ORCID 0000-0003-0447-0926 Ruddy Liendo-PicoagaUnidad Funcional de Gestión del Banco Nacional de Tumores, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima 15038, Peru.ORCID 0000-0003-3570-8802 Gustavo A SandovalResearch Group in Bioinformatics and Structural Biology, Faculty of Biological Sciences, National University of San Marcos (UNMSM), Lima 15081, Peru.ORCID 0000-0002-8392-9880 Marta Dueñas PortoInstitute of Biomedical Research, Hospital Universitario 12 de Octubre (IMAS12), 28041 Madrid, Spain.ORCID 0000-0003-0857-9726 Funding
Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica E073-2023-01Institute of Health Carlos III ISCIII, AC22/00015Scientific Foundation of the Spanish Association Against Cancer TRNSC213883DUEN and Transcan-3 JTC2022
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
biomarkersbreast cancerliquid biopsymiRNAsqRT-PCR
Identifiers
PMID42352419
PMCPMC13297568
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390